ArticleMolecular and clinical oncology2018

Metformin and aspirin treatment could lead to an improved survival rate for Type 2 diabetic patients with stage II and III colorectal adenocarcinoma relative to non-diabetic patients.

Ariella De Monte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.